By Sabela Ojea

AstraZeneca PLC said Friday that its independent nonexecutive director and chairman of the company's remuneration committee Michel Demare has been appointed as the new chairman-designate of the board.

The Anglo-Swedish pharma giant reiterated that the current chairman of the board, Leif Johansson, will be retiring in April 2023.

"Michel's appointment will take effect immediately on Leif's retirement allowing for a managed handover period over the coming months," AstraZeneca said.

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

(END) Dow Jones Newswires

July 29, 2022 03:04 ET (07:04 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Astrazeneca (LSE:AZN)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024 Haga Click aquí para más Gráficas Astrazeneca.
Astrazeneca (LSE:AZN)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024 Haga Click aquí para más Gráficas Astrazeneca.